McClung David Mark (CIK 0001811505)

Latest company ownership

Shares held
212,471
Last filed at
Nov 28, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 25, 2023 Nov 28, 2023 SANGAMO THERAPEUTICS, INC COO Sell 50.0 -1,925 -0.90% ✗ $735.5
Aug 25, 2023 Aug 29, 2023 SANGAMO THERAPEUTICS, INC COO Sell 50.0 -1,925 -0.89% ✗ $1.5K
Jun 25, 2023 Jun 26, 2023 SANGAMO THERAPEUTICS, INC COO Sell 46.3 -11,528 -5.17% ✗ $13.7K
May 25, 2023 May 30, 2023 SANGAMO THERAPEUTICS, INC COO Sell 50.0 -1,925 -0.86% ✗ $2.6K
Feb 24, 2023 Mar 6, 2023 SANGAMO THERAPEUTICS, INC COO Sell 91.3 +46,505 26.09% ✗ $25.9K
Jun 25, 2022 Jun 28, 2022 SANGAMO THERAPEUTICS, INC COO Sell 46.3 -11,525 -6.15% ✗ $49.7K
Feb 25, 2022 Mar 1, 2022 SANGAMO THERAPEUTICS, INC COO Sell 91.3 +54,790 42.08% ✗ $27.2K
Jun 25, 2021 Jun 29, 2021 SANGAMO THERAPEUTICS, INC EVP, Chief Business Officer Sell 42.5 -11,525 -8.18% ✗ $138.5K